Cargando…
Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis
INTRODUCTION: Current concepts of the pathophysiology of acute pancreatitis suggest that disease progression from acinar injury to systemic illness involves a complex interplay between cellular and soluble inflammatory mediators and endothelial beds. To date, there is no specific pharmacologic inter...
Autores principales: | Jamdar, Saurabh, Siriwardena, Ajith K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1269478/ https://www.ncbi.nlm.nih.gov/pubmed/16137370 http://dx.doi.org/10.1186/cc3777 |
Ejemplares similares
-
Contemporary management of infected necrosis complicating severe acute pancreatitis
por: Jamdar, Saurabh, et al.
Publicado: (2006) -
Anticoagulant properties of drotrecogin alfa (activated) during hemofiltration in patients with severe sepsis
por: de Pont, Anne CJM, et al.
Publicado: (2009) -
Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?
por: Friedrich, Jan O, et al.
Publicado: (2006) -
Introduction: severe sepsis and drotrecogin alfa (activated)
por: Artigas, Antonio, et al.
Publicado: (2007) -
Clinical trials in severe sepsis with drotrecogin alfa (activated)
por: Laterre, Pierre-François
Publicado: (2007)